Page 4«..3456..1020..»

You are currently browsing the Nano Medicine category

Increasing Trend of Nanomedical Devices And Therapeutic Market to Access Huge Growth by 2019-2025 Focusing on Leading Players PerkinElmer,Arrowhead…

§ November 26th, 2019 § Filed under Nano Medicine § Tagged Comments Off on Increasing Trend of Nanomedical Devices And Therapeutic Market to Access Huge Growth by 2019-2025 Focusing on Leading Players PerkinElmer,Arrowhead…

Crystal Market Research authorities conduct a triangulated approach of primary and secondary research on Global Nanomedical Devices And Therapeutic Market and carry out an in-depth analysis of multiple factors, including Nanomedical Devices And Therapeutic technological developments and the demand-supply shifts in various markets across the globe to accurately forecast the industrys growth possibilities. To assist clients to frame effective tactics for growth on global Nanomedical Devices And Therapeutic market for the period of 2019 to 2025.

It offers market insights from the statistics, gathered from reliable Nanomedical Devices And Therapeutic market informants such as manufacturers, channel partners, decision makers, and regulatory bodies. Based on various clients stipulations, Nanomedical Devices And Therapeutic also produces customized reports, which will help local vendors and global players cement their position in the chemicals and materials market.

Continue

Click Here for Get Sample Copy of this Report @https://www.crystalmarketresearch.com/report-sample/HC101499

The Nanomedical Devices And Therapeutic market outline segment of the report investigates progression, for example, drivers, limitations, and opportunities that, at present, strongly affect the market and could impact the market in future also. Nanomedical Devices And Therapeutic market share analysis has been given in the report with a particular ultimate objective to explain the power of contention between market players working over the globe.

Get it in discounted Price: https://www.crystalmarketresearch.com/check-discount/HC101499

Get Customized Research Report: https://www.crystalmarketresearch.com/customization/HC101499

Contacts Us:

Judy | 304 South Jones Blvd, Suite 1896

Las Vegas NV 89107

United States

E-mail: sales@crystalmarketresearch.com | Ph: +1-888-213-4282

More:
Increasing Trend of Nanomedical Devices And Therapeutic Market to Access Huge Growth by 2019-2025 Focusing on Leading Players PerkinElmer,Arrowhead...

Read the Rest...

Nanomedical Market Changing Market Trends, New Business Opportunities Analysis and Forecast with Revenue Growth 2019-2025 – Markets Gazette 24

§ November 26th, 2019 § Filed under Nano Medicine § Tagged Comments Off on Nanomedical Market Changing Market Trends, New Business Opportunities Analysis and Forecast with Revenue Growth 2019-2025 – Markets Gazette 24

New York, November 26, 2019: The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Nanomedical market share. Major industry players with significant revenue share include Johnson & Johnson, Mallinckrodt plc., Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, CombiMatrix Corporation, General electric Company, Sigma-Tau Pharmaceuticals, Inc., and others.

The Nanomedical Market is expected to exceed more than US$ 306 Billion by 2024 at a CAGR of 10.3% in the given forecast period.

Browse Full Report: https://www.marketresearchengine.com/nanomedical-market

Nanomedicine market is mainly driven by increase in acceptance of nanomedicine across diverse applications, rise in government funding & support, emerging technologies for drug delivery, rise in need for therapies with less side effects and allergies, and cost-effectiveness of therapies.

Growing healthcare facilities in developing countries are anticipated to bring numerous opportunities for the growth of nanomedicine market.

Nanomedicine is one of the applications of nanotechnology used in treatment, monitoring, diagnosis, and control of biological systems. Nanomedicine utilizes nanoscale control of materials to improve medicine delivery. Subsequently, nanomedicine has encouraged treatment against different diseases.

The global Nanomedical market is segregated on the basis of Indication as Ophthalmological Diseases, Immunological Diseases, Cardiovascular Diseases, Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Neurological Diseases, Urological Diseases, and Others. Based on Application the global Nanomedical market is segmented in Implants, Regenerative Medicine, Diagnostic Imaging, Drug Delivery, Vaccines, and Others. Based on Modality the global Nanomedical market is segmented in Treatments and Diagnostics.

The global Nanomedical market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Nanomedical market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Competitive Rivalry

Johnson & Johnson, Mallinckrodt plc., Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, CombiMatrix Corporation, General electric Company, Sigma-Tau Pharmaceuticals, Inc., and others are among the major players in the global Nanomedical market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

The Nanomedical Market has been segmented as below:

The Nanomedical Market is segmented on the lines of Nanomedical Market, By Indication, Nanomedical Market, By Application, Nanomedical Market, By Modality, Nanomedical Market, By Region and Nanomedical Market, By Company.

Nanomedical Market, By Indication this market is segmented on the basis of Ophthalmological Diseases, Immunological Diseases, Cardiovascular Diseases, Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Neurological Diseases, Urological Diseases and Others. Nanomedical Market, By Application this market is segmented on the basis of Implants, Regenerative Medicine, Diagnostic Imaging, Drug Delivery, Vaccines and Others. Nanomedical Market, By Modality this market is segmented on the basis of Treatments and Diagnostics. Nanomedical Market, By Region this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World. Nanomedical Market, By Company this market is segmented on the basis of Johnson & Johnson, Mallinckrodt plc., Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, CombiMatrix Corporation, General electric Company and Sigma-Tau Pharmaceuticals, Inc.

The report covers:

Report Scope:

The global Nanomedical market report scope includes detailed study covering underlying factors influencing the industry trends.

The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.

Reasons to Buy this Report:

Request Sample Report from here: https://www.marketresearchengine.com/nanomedical-market

Table of Contents:

Other Related Market Research Reports:

Biologic and Medical Imaging Reagents Market Overview and Share Forecasted to 2024 MRE Report

Hospital Supplies Market 2019 Perceive Substantial Growth During 2024 MRE Report

About MarketResearchEngine.com

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: john@marketresearchengine.com

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/

See the original post here:
Nanomedical Market Changing Market Trends, New Business Opportunities Analysis and Forecast with Revenue Growth 2019-2025 - Markets Gazette 24

Read the Rest...

Global Nanomedicine Market 2019 GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck & Co. Inc., Nanosphere Inc., Pfizer Inc. – The…

§ November 26th, 2019 § Filed under Nano Medicine § Tagged Comments Off on Global Nanomedicine Market 2019 GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck & Co. Inc., Nanosphere Inc., Pfizer Inc. – The…

The Nanomedicine report delivers a comprehensive and systematic framework of the worldwide Nanomedicine Market at a global level that includes all the key aspects related to it. The data is collected from different sources allied to the Nanomedicine and the research team meticulously analyze the gathered data with the help of various analytically tools and present their opinion based on analysis and calculations.

The Global Nanomedicine Market 2019 report offers clear-cut information about the key business-giants GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck & Co. Inc., Nanosphere Inc., Pfizer Inc., Sigma-Tau Pharmaceuticals Inc., Smith & Nephew PLC, Stryker Corp, Teva Pharmaceutical Industries Ltd., UCB (Union chimique belge) S.A challenging with each other in the worldwide Nanomedicine in terms of demand, sales, revenue generation, reliable products development, giving best services, and also post-sale processes at the global level.

To Get Free Sample Copy of Report Click Here: http://www.mrsresearchgroup.com/report/170399#request-sample

This Global Nanomedicine Market 2019 report is integrated with primary as well as secondary research of the Global industry. The worldwide Nanomedicine in detail and presents comprehensive forecasts regarding the markets growth trajectory during the forecast period (2019 2025)

The Global Nanomedicine Market 2019 report is based on key players, which are combined by market share, history of growth and Industry forecasts, it provides in-detailed information, basic needs of the market, and the report shows the how this market is growing Globally. The main regions that contribute to the worldwide Nanomedicine Market 2019 are United States, Europe, Japan, China, India, Southeast Asia.

This report holds each and every aspect of the international market for this specific domain, ranging from the primary market data to many important criteria, based on which, the worldwide Nanomedicine is standardized. The main functioning domains of the Nanomedicine are also covered based on their performance.

Request For Free Price Quotation @ http://www.mrsresearchgroup.com/report/170399#inquiry-for-buying

There are 15 Chapters to display the Global Nanomedicine Market 2019

Chapter 1, to describe worldwide Nanomedicine Market 2019 Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Nanomedicine Market 2019, with sales, revenue, and price of worldwide Nanomedicine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of worldwide Nanomedicine, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Global Nanomedicine Market 2019 forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Global Nanomedicine Market 2019 sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

In the end, worldwide Nanomedicine Industry 2019 report provides the main region, market conditions with the product price, profit, capacity, production, supply, demand, and market growth rate and forecast etc. This report also Present new project SWOT analysis, investment feasibility analysis, and investment return analysis.

Sorry! The Author has not filled his profile.

Link:
Global Nanomedicine Market 2019 GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck & Co. Inc., Nanosphere Inc., Pfizer Inc. - The...

Read the Rest...

Global Nanomedicine Market 2019 Industry Outlook, Comprehensive Insights, Growth and Forecast 2024 – The Chicago Sentinel

§ November 25th, 2019 § Filed under Nano Medicine § Tagged Comments Off on Global Nanomedicine Market 2019 Industry Outlook, Comprehensive Insights, Growth and Forecast 2024 – The Chicago Sentinel

MarketandResearch.bizhas recently announced the addition of new research report to its repository named,GlobalNanomedicine Market Research 2019 by Manufacturers, Regions, Countries, Types and Applications, Forecast to 2024. It provides a clear understanding of the market dynamics by studying the historical data and analyzing the current market situation. It aims to chalk the route of the market for the coming few years. It gives a comprehensive synopsis of the market picture including market overview, introduction, classification, market dynamics,and market size.

DOWNLOAD FREE SAMPLE REPORT:https://marketandresearch.biz/sample-request/85199

TheNanomedicinemarket research report includes a separate section which specifies key players profiles allowing understanding the pricing structure, cost,Nanomedicinecompany basic information, their contact details,and product category.

Main leading players in theNanomedicineMarket Are:, Combimatrix, Ablynx, Abraxis Bioscience, Celgene, Mallinckrodt, Arrowhead Research, GE Healthcare, Merck, Pfizer, Nanosphere, Epeius Biotechnologies, Cytimmune Sciences, Nanospectra Biosciences, ,

GlobalNanomedicinehas witnessed gradual growth in recent years and is expected to witness steady growth in the forecast period.In this report, theNanomedicinemarket is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2024, growing at a CAGR of XX% between 2019 and 2024.

TheNanomedicinereport contains brief information on these trends that can help the businesses operating in the industry to know constituents of the market and strategize for their business expansion accordingly. Moreover, various rudimentary aspects of theNanomedicinemarket such as market size, industry share, growth, key segments, and CAGR are also added in the report. The next section of the report serves detailed overview ofNanomedicineproduct specification, product type, product scope, and production analysis with key factors such as capacity, production, revenue, price and gross margin.

The notable feature of this report is that it presents an all-enclosing view of theNanomedicinemarket based on its segmentation, with respect to types, application, end-users, products, and geography.

The report executes the great study of capacity, production, revenue, price, gross margin, technology, demand-supply, consumption, import, export, market drivers and opportunities.It also discusseslimitations, risks, and challenges which will decide the standing future of the market all over the world.

The Study Report Provides In-depth Analysis On:

ACCESS FULL REPORT:https://marketandresearch.biz/report/85199/global-nanomedicine-industry-market-research-2019-by-manufacturers-regions-countries-types-and-applications-forecast-to-2024

Furthermore, manufacturing cost structure combines analysis of key raw materials, their price trends along with labor cost and manufacturing expenses. For market chain analysis, the report covers upstream raw materials, equipment, downstream buyers, marketing channels, and market development trend which more deeply include important information on key distributors/traders, major raw materials suppliers and contact information, major manufacturing equipment suppliers, major suppliers, and key consumers.

The report profiles SWOT analysis and market strategies of the key players. Any individual or organization interested in the report can greatly benefit from it. The market research data added in the study is the result of extensive primary and secondary research activities, surveys, personal interviews, and inputs from industry expert.

See more here:
Global Nanomedicine Market 2019 Industry Outlook, Comprehensive Insights, Growth and Forecast 2024 - The Chicago Sentinel

Read the Rest...

FYI on UTIs: All you need to know to treat and prevent urinary tract infections – GMA

§ November 25th, 2019 § Filed under Nano Medicine § Tagged Comments Off on FYI on UTIs: All you need to know to treat and prevent urinary tract infections – GMA

FYI on UTIs: All you need to know to treat and prevent urinary tract infections  GMA

See more here:
FYI on UTIs: All you need to know to treat and prevent urinary tract infections - GMA

Read the Rest...

Global Healthcare Nanotechnology Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2025 – Industry News Time 24

§ November 25th, 2019 § Filed under Nano Medicine § Tagged Comments Off on Global Healthcare Nanotechnology Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2025 – Industry News Time 24

A profound analysis of the industry based on the "Healthcare Nanotechnology Market" all over the world is named as Global Healthcare Nanotechnology Market Report. The research report assesses the current as well as the upcoming performance of the Healthcare Nanotechnology market, in addition to with newest trends in the market. The major player of the Healthcare Nanotechnology market (Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, Smith & Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Shire, Ipsen, Endo International)are also included in the market report. The report forecasts the future of the Healthcare Nanotechnology market on the basis of this evaluation.

The research analysis for Healthcare Nanotechnology market comprises each and every feature of the market all over the world, which starts from the Healthcare Nanotechnology market description and ends on the Healthcare Nanotechnology market segmentation (Nanomedicine, Nano Medical Devices, Nano Diagnosis, Other). In addition to this, each section of the Healthcare Nanotechnology market is categorized and evaluated on the basis of goods, the end-user clients of the Healthcare Nanotechnology market, and the employment of the products. The geographical categorization of the Healthcare Nanotechnology market (Anticancer, CNS Product, Anti-infective, Other) has also been evaluated thoroughly in the report.

Ask for sample link here: https://www.intenseresearch.com/market-analysis/global-healthcare-nanotechnology-market-2019-by-manufacturers-countries.html#request-sample

The Healthcare Nanotechnology perusers will discover this report exceptionally advantageous in the comprehension of the Healthcare Nanotechnology showcase in the nitty-gritty. The angles and data are spoken to in the Healthcare Nanotechnology report utilizing figures, structured presentations, pie graphs, and other visual portrayals. This escalates the Healthcare Nanotechnology pictorial portrayal and furthermore helps in getting the Healthcare Nanotechnology business actualities much better. The Healthcare Nanotechnology advertise is probably going to develop at a noteworthy CAGR. The principle goal of the Healthcare Nanotechnology report is to direct the client to comprehend the Healthcare Nanotechnology advertise as far as its definition, order, Healthcare Nanotechnology showcase potential, most recent patterns, and the difficulties that the Healthcare Nanotechnology advertises is confronting.

Questions replied in this Healthcare Nanotechnology report: https://www.intenseresearch.com/market-analysis/global-healthcare-nanotechnology-market-2019-by-manufacturers-countries.html

1. What will the Healthcare Nanotechnology advertise projection and what will the advancement rate by 2024?

2. What are the major Healthcare Nanotechnology advertise designs?

3. What is the development of driving components of the Healthcare Nanotechnology industry?

4. What are the snags being developed to the Healthcare Nanotechnology showcase?

5. Who are the Healthcare Nanotechnology driving sellers in a market?

6. What are the market space and limitations by the Healthcare Nanotechnology key sellers?

7. What are the Healthcare Nanotechnology driving sellers quality through SWOT and PESTEL consider?

Another area of the Healthcare Nanotechnology advertise report uncovers the procedure of creation. Be that as it may, this procedure gauges nitty-gritty Healthcare Nanotechnology think about with respect to assembling cost which incorporates crude stock, and diverse providers for modern offices.

Enquire about our report with our industry authority:

Overall Healthcare Nanotechnology Market Report Importance:

Our report significantly fixates around genuine research on each part and its general result on the Healthcare Nanotechnology showcase advance.

The objective gathering of watchers of the Healthcare Nanotechnology report acclimatizes new wannabes planning to wind up an expansive comprehension of the business, masters, monetary establishments, real accomplices, profitability, Healthcare Nanotechnology wholesalers, and industry organization.

To get the examination techniques those are being gathered by Healthcare Nanotechnology driving individual associations.

To have the misgiving without obstacles Healthcare Nanotechnology stance and a probability for the market.

Thanks for reading this article; you can also get individual chapter wise section or region wise report versions like North America, Europe or Asia.

About Us Market and Research are a trusted brand in the research industry with the capability of commissioning complex projects within a short span of time with a high level of accuracy. At Market and Research, we believe in building long term relations with our clients. Our services cover a broad spectrum of industries including Energy, Chemicals and Materials, Automotive and Aerospace.

Contact Us: Market and Research United States

Sorry! The Author has not filled his profile.

See original here:
Global Healthcare Nanotechnology Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2025 - Industry News Time 24

Read the Rest...

Stanford postdoc and students cited as example to girls interested in STEM fields | The Dish – Stanford University News

§ November 25th, 2019 § Filed under Nano Medicine § Tagged Comments Off on Stanford postdoc and students cited as example to girls interested in STEM fields | The Dish – Stanford University News

by Alex Kekauoha on November 24, 2019 10:31 am

Dorothy Tovar, PhD student in microbiology and immunology, is among those selected to be an IF/THEN ambassador. (Courtesy Dorothy Tovar)

Three Stanford students and one postdoctoral scholar have been selected to the first class of IF/THEN ambassadors for the American Association for the Advancement of Science. Each will provide support and mentorship to young girls interested in pursuing STEM fields.

Catie Cuan

Graduate students CATIE CUAN and DOROTHY TOVAR, postdoctoral scholar HELEN TRAN and undergraduate ERIN SMITHare among 125 women selected to serve as ambassadors.

The ambassadors recently attended the IF/THEN Summit in Dallas, Texas, where they participated in a full-body scan that produced life-sized 3D-printed statues of the ambassadors the largest collection of statues of women. Ambassadors will also work with Bay Area Girl Scout troops, appear on the network television series Mission Unstoppable about women working on cutting-edge STEM projects and participate in media campaigns.

The IF/THEN initiative is based on the idea that if women in STEM fields are supported, then they can change the world. The program is supported by a $25 million commitment from Dallas-based Lyda Hill Philanthropies. It is also a partnership with the American Association for the Advancement of Science, which works to advance science, engineering and innovation throughout the world for the benefit of all people.

Catie Cuan is a PhD candidate in the Department of Mechanical Engineering. Growing up in Berkeley, California, she loved math and science, but had few female role models in those fields.

Helen Tran

This resulted in a self-imposed narrowing of what my future possibilities were, she said.

Cuan earned a bachelors degree from the University of California, Berkeley, and has had a career as a dancer and choreographer. After making performances and art installations with robots, she decided to pursue a graduate degree in mechanical engineering.Cuan is currently designing physical interactions between humans and robots, as well as haptic devices to tele-operate robots.

Helen Tran is the Intelligence Community postdoctoral fellow in the lab of Professor Zhenan Bao in the Department of Chemical Engineering.

A native of San Jose, California, science was not on Trans radar until college. She earned a bachelors degree in chemistry from the University of California, Berkeley, and a PhD in chemistry from Columbia University. She joined Stanford in 2016 and is currently researching biodegradable stretchable electronics.

Through the IF/THEN program, Tran has enjoyed learning about the quantitative studies on the importance of media representation of women in media.

Dorothy Tovar is a PhD student studying microbiology and immunology.

Erin Smith

Growing up in Cambridge, Massachusetts, Tovar became interested in science at a young age. She frequently read science books and encyclopedias and watched countless hours of the Discovery Channel. She also spent some of her childhood in Haiti, where she became fascinated by the way microscopic organisms could cause diseases that devastate entire countries.

Tovar earned a BS in microbiology from the University of Massachusetts, Amherst, where she was awarded the universitys 21st Century Leader Award. She joined Stanford Medicine in 2015.

Erin Smith, a first-year student and native of Kansas, is the founder ofFacePrint, an AI tool to detect and monitor Parkinsons disease and commonly misidentified neurological disorders using video technology and early-stage facial expression indicators. She is currently off campus pursuing a Thiel Internship.

Smiths research interest was spurred when she watched a video by the Michael J. Fox Foundation and noticed that Parkinsons patients smiles and laughter often appeared emotionally distant years before diagnosis. She talked to clinicians and caretakers, who reported similar observations. As she read through past medical papers. she found that the often-overlooked parts of the brain that experience some of the earliest changes in Parkinsons patients are the same parts involved in the formation of facial expressions. Smith became captivated by the idea of using facial expressions to monitor changes in the brain like Parkinsons and objectively detect its onset.

Mentors have had a pivotal impact on my life, said Smith. I am looking forward to the opportunity to engage with young students and help shape their futures.

Read more in the Roundabout.

See original here:
Stanford postdoc and students cited as example to girls interested in STEM fields | The Dish - Stanford University News

Read the Rest...

Sorry, there’s no cure for the common cold: Opinion – CBC.ca

§ November 25th, 2019 § Filed under Nano Medicine § Tagged Comments Off on Sorry, there’s no cure for the common cold: Opinion – CBC.ca

The common cold makes us feel miserable sore throat, sinus congestion, runny nose, sore or plugged ears, coughing but please don't ask for antibiotics to fix it.

Despite all of the advances in medicine the old saying remains true: there is no cure for the common cold.

Many people believe antibiotics will help end or shorten a cold. Unfortunately, that is not the case.

Infections come in different flavours, depending on what microscopic organism or bug is responsible. Two big groups of infection-causing organisms are viruses and bacteria.

Viruses and bacteria are very different. Bacteria are living, tiny, single cells that can replicate all on their own. Viruses aren't full cells. They require an actual cell (like your sinus or lung cells) to help them replicate and cause infection.

Antibiotics are drugs that stop or kill bacteria only.They prevent the bacteria from replicating: for example, by poking holes in the bacterial cell wall.

Here's the thing: colds are caused by viruses.

Viruses are so vastly different than bacteria that antibiotics do nothing to stop them or even slow them down.

Think of a balloon and a bowling ball.If you want to destroy the balloon, you could use a sharp pin.But if you want to destroy the bowling ball, your pin is useless. It's the wrong tool for the job.

While there are some antiviral medications out there (examples are HIV treatment or cold sore medication), there are none that work on the many viruses that cause colds.

The great majority of colds run their course and disappear. On occasion, however, colds can get complicated.

When your ears and lungs are plugged up with the usual mucus that comes with a cold, the bacteria that hang around your body can sometimes take advantage of their changed environment, and cause an infection of their own.

Signs that you may have developed a bacterial infection include high fever or chills, or sudden new pain in one place (your ear, chest, or a sinus).

Green or yellow mucus from your nose or chest can be from a viral or bacterial infection (the green colour comes from your own immune cells, not the bug), but a big change in the colour or amount of mucus could mean trouble.

The timeline also matters. A cold should run from five to 10 days (though sometimes the cough hangs on for a few weeks) and you should be feeling gradually better toward the end.Starting to suddenly feel worse can be a bad sign.

No single symptom or sign will confirm you have a bacterial infection.But your doctor can look at the whole picture and decide how likely it is that you might need treatment for one with antibiotics.

For people with a known lung disease like asthma or chronic obstructive pulmonary disease, the lungs aren't normal. If you have a lung disease, check with your doctor for what to do when you get chest infection symptoms.

If you are diagnosed with a bacterial infection, you'll be prescribed antibiotics. It is very important to use them properly, as instructed by your doctor and pharmacist.

These drugs aren't fail-safe. Because bacteria are living organisms, they can mutate and adapt to become better at surviving a course of antibiotics. This phenomenon is called antibiotic resistance.

Antibiotic resistance is developing faster than we can come up with new antibiotics.It is a very real and difficult problem.

It is more likely to happen if antibiotics aren't taken at the right dose, or for the right length of time.

You should only use antibiotics prescribed to you for a certain condition.Not "leftover" ones, or ones prescribed to someone else. They may not be adequate to kill your infection, and could contribute to bacteria becoming antibiotic-resistant.

And a final way we can fight against antibiotic resistance?Not using them unnecessarily like for the common cold.

This column is part of CBC's Opinion section. For more information about this section, please readour FAQ.

See the original post here:
Sorry, there's no cure for the common cold: Opinion - CBC.ca

Read the Rest...

NanoRobotics Market Overview on Future Threats by 2026 – Crypto News Byte

§ November 25th, 2019 § Filed under Nano Medicine § Tagged Comments Off on NanoRobotics Market Overview on Future Threats by 2026 – Crypto News Byte

According to Stratistics MRC, the Global Nanorobotics Market is accounted for $4.10 Billion in 2017 and is expected to reach $11.88 Billion by 2026 growing at a CAGR of 12.5% during the forecast period. Growing application of nanotechnology and regenerative medicine, rising acceptance and preferment of entrepreneurship and increasing investments by government and universities are the key factors fuelling the market growth. However, high manufacturing cost may hinder the growth of the market.

Nanorobotics is an evolving technology arena that creates robots or machines which have machinery near to the scale of a nanometre (109 meters). It denotes the nanotechnology engineering regulation of planning, designing, and building nanorobots, primarily from molecular components. Nanorobotics is an attractive new field, especially in medicine, which focus on directed drug delivery using nanoscale molecular machines.

Request For Report sample @: https://www.trendsmarketresearch.com/report/sample/11327

By Type, Nanomanipulator is expected to hold considerable market growth during the forecast period. Nanomanipulator is a specialized nanorobot and microscopic viewing system for working with objects on an extremely small scale. Nanomanipulators are mainly used to influence the atoms and molecules and were among the first nanorobotic systems to be commercially accessible. By geography, Europe dominated the highest market share due to rising aging population and rising governmental healthcare expenditure.

Some of the key players in Nanorobotics include Bruker, JEOL, Thermo Fisher Scientific, Ginkgo Bioworks, Oxford Instruments, EV Group, Imina Technologies, Toronto Nano Instrumentation, Klocke Nanotechnik, Kleindiek Nanotechnik, Xidex, Synthace, Park Systems, Smaract and Nanonics Imaging

Types Covered: Nanomanipulator Magnetically Guided Bacteria-Based Bio-Nanorobotics

Applications Covered: Biomedical Nanomedicine Mechanical Other Applications

Request For Discount On This Report at: https://www.trendsmarketresearch.com/report/discount/11327

Regions Covered: North Americao USo Canadao Mexico Europeo Germanyo UKo Italyo Franceo Spaino Rest of Europe Asia Pacifico Japano Chinao Indiao Australiao New Zealando South Koreao Rest of Asia Pacific South Americao Argentinao Brazilo Chileo Rest of South America Middle East & Africao Saudi Arabiao UAEo Qataro South Africao Rest of Middle East & Africa

What our report offers: Market share assessments for the regional and country level segments Market share analysis of the top industry players Strategic recommendations for the new entrants Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) Strategic recommendations in key business segments based on the market estimations Competitive landscaping mapping the key common trends Company profiling with detailed strategies, financials, and recent developments Supply chain trends mapping the latest technological advancements

Free Customization Offerings:All the customers of this report will be entitled to receive one of the following free customization options: Company Profilingo Comprehensive profiling of additional market players (up to 3)o SWOT Analysis of key players (up to 3) Regional Segmentationo Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check) Competitive Benchmarkingo Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Read more:
NanoRobotics Market Overview on Future Threats by 2026 - Crypto News Byte

Read the Rest...

Capital Digestive Care Taps 3 GIs for Maryland Locations – GlobeNewswire

§ November 23rd, 2019 § Filed under Nano Medicine § Tagged Comments Off on Capital Digestive Care Taps 3 GIs for Maryland Locations – GlobeNewswire

Drs. Stephen J. Park, Erica R. Cohen, and Katherine J. Hahn join Capital Digestive Care in suburban Maryland.

Silver Spring, MD, Nov. 22, 2019 (GLOBE NEWSWIRE) -- Washington, DC metropolitan-based health care provider Capital Digestive Care has welcomed three new specialists to its suburban locations. All of the physicians are highly accomplished and board-certified with a solid commitment to patient care.

Erica R. Cohen, MD recently joined Capital Digestive Care in Chevy Chase, Maryland. Prior to joining Capital Digestive Care, she practiced medicine as an advanced inflammatory bowel disease fellow at Cedars Sinai Medical Center in Los Angeles, California. As a trained Inflammatory Bowel Disease specialist, she has unique expertise in Crohns disease, ulcerative colitis, microscopic colitis, and refractory c. difficile colitis infection. In addition, she treats a wide range of concerns such as celiac disease, colon cancer screening, and diverticular disease.Her personal philosophy involves a multi-disciplinary approach to patient care, which includes ongoing discussions with the entirety of the care team while putting the patient at the forefront of the decision-making. She sees cultivating the patient-physician relationship as critical to achieving the best possible outcomes.

Stephen J. Park, MD recently joined Capital Digestive Cares locations in Frederick, Ijamsville, and Rockville, Maryland. He previously served as Medical Director of the Gastroenterology clinic at Joint Base Andrews in Prince Georges County, Maryland. In addition, he cared for patients at Walter Reed National Military Medical Center and Fort Belvoir Community Hospital, while holding a faculty appointment as Assistant Professor of Medicine for the Uniformed Services University of the Health Sciences. Dr. Park has had multiple publications and presentations at national meetings in gastroenterology and hepatology, and he won the Excellence in Research Award during fellowship. He also served on active duty as an officer in the United States Air Force for 10 years, earning the Air Force and Army Achievement Medals for meritorious service.He began his medical training in an accelerated combined Bachelor of Science/Doctor of Medicine program, graduating magna cum laude from Villanova University and earning his medical degree from Drexel University College of Medicine. Thereafter, he completed his residency in internal medicine at the San Antonio Uniformed Services Health Education Consortium and followed up there with a gastroenterology fellowship in which he was selected for advanced endoscopic ultrasound training.

Katherine J. Hahn, MD, MPH recently joined Capital Digestive Cares locations in Silver Spring and Rockville, Maryland with a strong academic background and a commitment to the community. She earned her Bachelor of Arts in Sociology from Northwestern University and continued her education at The Feinberg School of Medicine, Northwestern University in Chicago, IL. Prior to residency, Dr. Hahn received a Master of Public Health from Johns Hopkins University, where she focused on Patient Safety and Health Care Quality Improvement. She completed her Internal Medicine Residency at Georgetown University Hospital in Washington, DC and served as Chief Medical Resident. During her residency, she also received the prestigious Johnson & Johnson Global Health Scholar award and was selected by the American Association for Liver Diseases as an Emerging Liver Scholar. She followed up at Georgetown University Hospital by completing a fellowship in Gastroenterology and Hepatology.Dr. Hahn has contributed to many peer-reviewed publications, presentations, and abstracts on the topics of liver disease, inflammatory bowel disease, colonoscopy, and patient safety. In addition to English, she speaks fluent Korean.

Capital Digestive Care is the Washington metropolitan area's founding group of digestive care doctors. Anyone who would like to learn more about Capital Digestive Care's physicians or locations should visit the company's website.

About Capital Digestive Care:

Founded in 2009, Capital Digestive Care is a Washington, DC metropolitan-based health care provider with a focus on gastroenterology and hepatology. With 13 office locations, its physicians treat a wide range of conditions - from heartburn to constipation to fatty liver disease - and offer critical services for the prevention of colon cancer. Capital Digestive Cares integrated health care model connects its doctors to both a specialized pathology laboratory and the largest clinical research program of its kind in the region, as well as 13 hospital affiliations and 8 ambulatory surgical centers. Capital Digestive Cares physicians work together across disciplines to develop the most effective treatment plan for each patient. For more information on Capital Digestive Care, please visithttp://www.capitaldigestivecare.com/.

Read more:
Capital Digestive Care Taps 3 GIs for Maryland Locations - GlobeNewswire

Read the Rest...

Global Nanorobotics Market : Industry Analysis and Forecast (2018-2026) – The Market Expedition

§ November 23rd, 2019 § Filed under Nano Medicine § Tagged Comments Off on Global Nanorobotics Market : Industry Analysis and Forecast (2018-2026) – The Market Expedition

Global Nanorobotics Marketwas valued at US$ 3.7 Bn in 2017 and is expected to reach US$ 9.2Bn by 2026, at a CAGR of 12.06%during a forecast period.Global Nanorobotics MarketDevelopments in nanotechnology coupled with demand for minimally aggressive procedures are expected to drive market growth over the forecast period. Nanobots possess likely in the medical sector for destroying cancerous cells at the genetic level. Increasing support for nanomedicine by many nations and the increasing geriatric population are factors which can augur market demand.

Utilization of nanobots in the ranostics can be beneficial for the market in the near future. A rise in miniaturization and demand for automation across various sectors are anticipated to fuel market growth. Training of new personnel to use nanobots can restrain market growth in the upcoming years.Nanomedicine application segment to grow at the highest CAGR during the forecast period. Nanorobotics is widely used in nanomedicine owning to its healthcare features. The large share of this application aspects to the large level of commercialization in the healthcare sector for drug delivery, in vivo imaging, biomaterial, in vitro diagnostic, active implants, and drug therapy.

North America region accounted for the largest share of 12.2%, in terms of value, of the nanorobotics market globally. Presence of many nanotechnology companies, well-developed healthcare infrastructure, and government initiatives to create patient awareness are factors driving the market. The U.S is anticipated to contribute to market revenue owing to the increase in cardiovascular diseases and the rising elderly populace.

REQUEST FOR FREE SAMPLE REPORT:https://www.maximizemarketresearch.com/request-sample/30888

Europe follows North America as the second biggest nanorobotics market. Presence of chronic diseases and the burgeoning population are factors expected to indicate the Europe nanobots market. Establishment of organizations to develop standards pertaining to nanotechnology can expand market growth. In 2018, DNA-Robotics, an organization including 12 European companies, has outlined steps to expedite production of nanobots on a large scale. These standards can help scale the market exponentially in the upcoming years.

A recent development in nanorobotics market: In March 2018, Thermo Fisher Scientific acquired Gatan, an exclusively owned subsidiary of Roper Technologies. Gatan is an electron microscopy solutions provider in the U.S, which accompaniments the Thermo Fisher Scientifics electron microscopy solutions business.In March 2017, Oxford Instruments (U.K) Asylum Research introduced its new SurfRider HQ-Series of high quality, budget-priced AFM probes, which are also existing in a model suitable for nanomechanical image mode.

The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Nanorobotics Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTERs analysis, SWOT analysis to address the question of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in the Global Nanorobotics Market.

DO INQUIRY BEFORE PURCHASING REPORT HERE:https://www.maximizemarketresearch.com/inquiry-before-buying/30888

Scope of the Global Nanorobotics Market

Global Nanorobotics Market, By Type

Nanomanipulatoro Electron Microscope (EM) Scanning Electron Microscope (SEM) Transmission Electron Microscope (TEM)o Scanning Probe Microscope (SPM) Atomic Force Microscopes (AFM) Scanning Tunneling Microscope (STM) Bio-Nanorobotics Magnetically Guided Bacteria-Based

Global Nanorobotics Market, By Application

Nanomedicine Biomedical Mechanical Others

Global Nanorobotics Market, By Region

North America Europe Asia Pacific Middle East and Africa South America

Key players operating in Global Nanorobotics Market:

Bruker JEOL Thermo Fisher Scientific Ginkgo Bioworks Oxford Instruments EV Group Imina Technologies Toronto Nano Instrumentation KlockeNanotechnik KleindiekNanotechnik Xidex Synthace Park Systems Smaract Nanonics Imaging

Key Innovators:

Novascan Technologies Angstrom Advanced Hummingbird Scientific NT-MDT Spectrum Instruments Witec

Browse Full Report with Facts and Figures of nanorobotics Market Report at:https://www.maximizemarketresearch.com/market-report/global-nanorobotics-market/30888/

MAJOR TOC OF THE REPORT

Chapter One: nanorobotics Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global nanorobotics Market Competition, by Players

Chapter Four: Global nanorobotics Market Size by Regions

Chapter Five: North America nanorobotics Revenue by Countries

Chapter Six: Europe nanorobotics Revenue by Countries

Chapter Seven: Asia-Pacific nanorobotics Revenue by Countries

Chapter Eight: South America nanorobotics Revenue by Countries

Chapter Nine: Middle East and Africa Revenue nanorobotics by Countries

Chapter Ten: Global nanorobotics Market Segment by Type

Chapter Eleven: Global nanorobotics Market Segment by Application

Chapter Twelve: Global nanorobotics Market Size Forecast (2019-2026)

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Lumawant Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Contact: +919607065656/ +919607195908

Website: http://www.maximizemarketresearch.com

Read the original post:
Global Nanorobotics Market : Industry Analysis and Forecast (2018-2026) - The Market Expedition

Read the Rest...

Eight Illinois researchers rank among world’s most influential – University of Illinois News

§ November 23rd, 2019 § Filed under Nano Medicine § Tagged Comments Off on Eight Illinois researchers rank among world’s most influential – University of Illinois News

CHAMPAIGN, Ill. Eight faculty members at the University of Illinois at Urbana-Champaign have been named to the 2019 Highly Cited Researchers list, a global listing of scientists who produced the past decades most influential papers, compiled by the Web of Science group, a Clarivate Analytics company.

The list recognizes researchers who produced multiple papers ranking in the top 1% by citations for their field and year of publication, demonstrating significant research influence among their peers, according to Web of Science. It selected 6,216 researchers for their performance in 21 fields and for cross-field influence in scholarly publications from 2008 to 2018.

The Illinois faculty include crop sciencesandplant biologyprofessorElizabeth Lisa Ainsworth(highly cited for cross-field impact), materials science and engineering professor Axel Hoffmann (cross-field), electrical and computer engineering professor Thomas Huang (engineering), geography and geographic information professor Mei-Po Kwan (cross-field), crop sciencesandplant biologyprofessorStephen P. Long(cross-field), bioengineering professor Shuming Nie (cross-field), plant biology professorDonald Ort(plant and animal science), and mechanical science and engineering professor Arend van der Zande (cross-field).

Lisa Ainsworth, crop sciences and plant biology

Photo by L. Brian Stauffer

Edit embedded media in the Files Tab and re-insert as needed.

Ainsworth leads the U.S. Department of Agriculture Agricultural Research Services Global Change and Photosynthesis Research Unit. Her research examines genetic variation in crop responses to air pollution and climate change. She received the 2019 Prize in Food and Agricultural Research from the National Academy of Sciences and is an affiliate of the Carl R. Woese Institute for Genomic Biology at Illinois.

Axel Hoffmann, materials science and engineering

Photo by L. Brian Stauffer

Edit embedded media in the Files Tab and re-insert as needed.

Hoffmann is a Founder Professor in materials science and engineering and a member of the Materials Research Laboratory. His research focuses on topics related to magnetism, such as spin transport, magnetization dynamics and biomedical applications. His work on spin Hall effects has contributed to the development of spintronics, electronic devices that harness electron spin for faster and more efficient computing. Hoffmann is a Fellow of the American Vacuum Society, the American Physical Society and the Institute of Electrical and Electronics Engineers.

Thomas Huang, electrical and computer engineering

Photo by L. Brian Stauffer

Edit embedded media in the Files Tab and re-insert as needed.

Huang is the Maybelle Leland Swanlund Endowed Chair Emeritus in Electrical and Computer Engineering. He studies many fields related to computer engineering and artificial intelligence, including human-computer interaction, multimedia signal processing, computer vision, big data and machine learning. He retired from teaching in 2014, but remains active as a researcher. He also is affiliated with the Beckman Institute for Advanced Science and Technology.

Mei-Po Kwan, geography and geographic information

Photo courtesy of Mei-Po Kwan

Edit embedded media in the Files Tab and re-insert as needed.

Kwan investigates health, transportation and urban issues using innovative geographic information system methods. Her work encompasses environmental health, human mobility, access to health care, neighborhood effects, sustainable travel and cities, and the application of GIS methods in geographic research. Kwan is a Fellow of the American Association for the Advancement of Science and the U.K. Academy of Social Sciences. Among other honors, she received a Guggenheim Fellowship in 2016 and Distinguished Scholarship Honors from the American Association of Geographers in 2011.

Stephen Long, crop sciences and plant biology

Photo by L. Brian Stauffer

Edit embedded media in the Files Tab and re-insert as needed.

Long is the Stanley O. Ikenberry Chair of Crop Sciences and Plant Biology. He uses computational and experimental approaches to improve photosynthetic efficiency, and works to address the effects of climate change on crop yield. He was elected a Fellow of the Royal Society of London in 2013, and has been recognized as a highly cited researcher in the field of plant and animal science every year since 2005. He directs Realizing Increased Photosynthetic Efficiency, a multinational project supported by the Bill & Melinda Gates Foundation, the Foundation for Food and Agricultural Research, and the U.K. Department for International Development. He is a member of the IGB.

Shuming Nie, bioengineering

Photo courtesy of bioengineering department

Edit embedded media in the Files Tab and re-insert as needed.

Nie is the Grainger Distinguished Chair in Bioengineering and a professor of chemistry, materials science and engineering, and electrical and computer engineering. He studies nanomedicine, molecular engineering and image-guided minimally invasive robotic surgery. He is as Fellow of the AAAS, the American Institute of Medical and Biological Engineering, and the International Academy of Medical and Biological Engineering.

Donald Ort, crop sciences and plant biology

Photo by L. Brian Stauffer

Edit embedded media in the Files Tab and re-insert as needed.

Ort is the Robert Emerson Professor of Plant Biology and Crop Sciences. His research focuses on improving photosynthesis and addresses crop responses to global change factors including increases in atmospheric carbon dioxide and temperature. He leads the Genomic Ecology of Global Change theme in the IGB and was elected to the National Academy of Sciences in 2017.

Arend van der Zande, mechanical science and engineering

Photo by Julia Stackler

Edit embedded media in the Files Tab and re-insert as needed.

Van der Zande specializes in multidisciplinary nanoscience; specifically, his group uses two-dimensional materials, such as membranes and thin films, as molecular building blocks to construct new devices with applications in electronics, sensing, energy and more. He has affiliations with the Materials Research Laboratory, the Holonyak Micro and Nano Technology Laboratory, the Beckman Institute and the department of electrical and computer engineering.

Continue reading here:
Eight Illinois researchers rank among world's most influential - University of Illinois News

Read the Rest...

Scientists unravel mysteries of cells’ whiplike extensions – Washington University School of Medicine in St. Louis

§ November 22nd, 2019 § Filed under Nano Medicine § Tagged Comments Off on Scientists unravel mysteries of cells’ whiplike extensions – Washington University School of Medicine in St. Louis

Visit the News Hub

Describing the structure of cilia opens doors to understanding range of diseases

Cilia contain structures called ciliary doublet microtubules. Pictured is a cross section of one of these structures. A new study from Washington University School of Medicine in St. Louis and Harvard Medical School has described the most detailed picture yet of these vital cellular structures. The microtubule is shown in gray, and the newly identified proteins decorating the microtubule are depicted in various colors.

Cilia, or flagella whiplike appendages on cells perform diverse tasks required to keep the body healthy. When cilia malfunction, the consequences can be devastating, causing a range of problems, from blindness, to lung and kidney diseases, to congenital heart defects. Now, scientists have revealed the first detailed look at the inner structure of cilia.

The newly revealed structure offers a starting point to begin exploring how cilia are assembled during development, how they are maintained over a cells life span, and how they might become dysfunctional if some of the cogs in these complex molecular machines are mutated or missing. The structure of these microscopic molecular machines common to cells in organisms from algae to people potentially will answer questions about human health and disease.

The research, by investigators at Washington University School of Medicine in St. Louis and Harvard Medical School, was published recently in the journal Cell.

This new study is exciting because it fills in a lot of missing information about the structure of cilia, said senior author Rui Zhang, PhD, an assistant professor of biochemistry and molecular biophysics at Washington University. When cilia dont work properly, bad things happen. We need to know details of the structure in order to develop treatments for diseases, or strategies to prevent the developmental defects that can occur in the early embryo if the cilia are not functioning as they should.

In the respiratory tract, cilia move mucus and protect against viral and bacterial illnesses. In the reproductive tract, they propel sperm to fertilize an egg. Cilia also perform vital tasks in the brain, the kidney, the pancreas and in bone growth. And in the earliest stages of development, the rotational motion of specialized cilia in the embryo defines the bodys left-right asymmetry and where organs are placed. Without properly functioning cilia, the heart may not end up on the left side, where it should be, and it may not function properly.

Cilia are implicated in multiple human disorders, including polycystic kidney disease, which affects some 600,000 Americans and requires dialysis; primary ciliary dyskinesia, which causes chronic lung disease, misplaced organs and infertility; Bardet-Biedl syndrome, which causes patients to become blind in childhood and leads to diabetes, kidney disease and extreme obesity; and many congenital heart defects, which occur when left-right asymmetry goes awry and require complex surgeries to repair.

In the new study, the researchers used a technique called single particle cryo-electron microscopy to get a first look at 33 specific proteins arranged inside cilia within structures called ciliary microtubule doublets in a strict repeating pattern.

Before this work, everyone assumed these proteins inside cilia just stabilize the structure, which is true for a subset of the proteins, especially when you consider the forces produced by the continuous beating of the cilia, Zhang said. But based on how they are arranged inside this structure, we believe these proteins are doing many more things.

Since many of the proteins protrude through the cilia, Zhang and his colleagues speculate that they may allow for communication between the inside and the outside of the ciliary microtubule doublets; govern the function of enzymes that make important biochemical reactions possible; and sense changes in the calcium concentration of the environment, which plays a role in triggering the cilia to beat.

Among the proteins identified, five are associated with diseases that have been studied in mice and people, said co-author Susan K. Dutcher, PhD, a professor of genetics at Washington University. But until now, no one knew that these proteins were found inside cilia. We are just beginning to understand their roles in normal and disease states.

The researchers studied cilia in a type of algae calledChlamydomonas reinhardtii, which are single-celled organisms that have cilia structurally and biochemically similar to those of more complex organisms, including people. One question Dutcher is interested in answering is how the proteins making up cilia structure govern the type of motion that the cilia perform. The cilia of single-celled C. reinhardtii are capable of more than one type of motion.

In some situations, the cilia are doing what you might consider a breast stroke, Dutcher said. In others, the motion is more of an S-shaped wave. The cilia of many cells in mammals can only produce one of these motions. But the single-celled C. reinhardtii, perhaps to help it adapt to its environment, can switch between them. Thats why were studying algae at a medical school the genetic problems we can study in the cilia of these organisms are similar to the ones that can occur in people, often with devastating consequences.

Zhang, Dutcher and their colleagues have plans to use the latest techniques of cryo-electron microscopy to study the Chlamydomonas mutants of each of the 33 proteins inside cilia to seek answers to many questions that have arisen from this new and detailed knowledge of the structure.

This work was supported by the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH), grant number R01GM032843; the International Retinal Research Foundation; the E. Matilda Ziegler Foundation for the Blind; the Smith Family Foundation; and the Pew Charitable Trusts.

Ma M, Stoyanova M, Rademacher G, Dutcher SK, Brown A, Zhang R. Structure of the decorated ciliary doublet microtubule. Cell. Oct. 31, 2019.

Washington University School of Medicines 1,500 faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Childrens hospitals. The School of Medicine is a leader in medical research, teaching and patient care, ranking among the top 10 medical schools in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Childrens hospitals, the School of Medicine is linked to BJC HealthCare.

Go here to read the rest:
Scientists unravel mysteries of cells' whiplike extensions - Washington University School of Medicine in St. Louis

Read the Rest...

Capital Digestive Care Taps 3 GIs for Maryland Locations – Yahoo Finance

§ November 22nd, 2019 § Filed under Nano Medicine § Tagged Comments Off on Capital Digestive Care Taps 3 GIs for Maryland Locations – Yahoo Finance

Punctuating a year of healthy growth, Capital Digestive Care brings three new gastroenterologists on board.

Silver Spring, MD, Nov. 22, 2019 (GLOBE NEWSWIRE) -- Washington, DC metropolitan-based health care provider Capital Digestive Care has welcomed three new specialists to its suburban locations. All of the physicians are highly accomplished and board-certified with a solid commitment to patient care.

Erica R. Cohen, MD recently joined Capital Digestive Care in Chevy Chase, Maryland. Prior to joining Capital Digestive Care, she practiced medicine as an advanced inflammatory bowel disease fellow at Cedars Sinai Medical Center in Los Angeles, California. As a trained Inflammatory Bowel Disease specialist, she has unique expertise in Crohns disease, ulcerative colitis, microscopic colitis, and refractory c. difficile colitis infection. In addition, she treats a wide range of concerns such as celiac disease, colon cancer screening, and diverticular disease.Her personal philosophy involves a multi-disciplinary approach to patient care, which includes ongoing discussions with the entirety of the care team while putting the patient at the forefront of the decision-making. She sees cultivating the patient-physician relationship as critical to achieving the best possible outcomes.

Stephen J. Park, MD recently joined Capital Digestive Cares locations in Frederick, Ijamsville, and Rockville, Maryland. He previously served as Medical Director of the Gastroenterology clinic at Joint Base Andrews in Prince Georges County, Maryland. In addition, he cared for patients at Walter Reed National Military Medical Center and Fort Belvoir Community Hospital, while holding a faculty appointment as Assistant Professor of Medicine for the Uniformed Services University of the Health Sciences. Dr. Park has had multiple publications and presentations at national meetings in gastroenterology and hepatology, and he won the Excellence in Research Award during fellowship. He also served on active duty as an officer in the United States Air Force for 10 years, earning the Air Force and Army Achievement Medals for meritorious service.He began his medical training in an accelerated combined Bachelor of Science/Doctor of Medicine program, graduating magna cum laude from Villanova University and earning his medical degree from Drexel University College of Medicine. Thereafter, he completed his residency in internal medicine at the San Antonio Uniformed Services Health Education Consortium and followed up there with a gastroenterology fellowship in which he was selected for advanced endoscopic ultrasound training.

Katherine J. Hahn, MD, MPH recently joined Capital Digestive Cares locations in Silver Spring and Rockville, Maryland with a strong academic background and a commitment to the community. She earned her Bachelor of Arts in Sociology from Northwestern University and continued her education at The Feinberg School of Medicine, Northwestern University in Chicago, IL. Prior to residency, Dr. Hahn received a Master of Public Health from Johns Hopkins University, where she focused on Patient Safety and Health Care Quality Improvement. She completed her Internal Medicine Residency at Georgetown University Hospital in Washington, DC and served as Chief Medical Resident. During her residency, she also received the prestigious Johnson & Johnson Global Health Scholar award and was selected by the American Association for Liver Diseases as an Emerging Liver Scholar. She followed up at Georgetown University Hospital by completing a fellowship in Gastroenterology and Hepatology.Dr. Hahn has contributed to many peer-reviewed publications, presentations, and abstracts on the topics of liver disease, inflammatory bowel disease, colonoscopy, and patient safety. In addition to English, she speaks fluent Korean.

Capital Digestive Care is the Washington metropolitan area's founding group of digestive care doctors. Anyone who would like to learn more about Capital Digestive Care's physicians or locations should visit the company's website.

About Capital Digestive Care:

Founded in 2009, Capital Digestive Care is a Washington, DC metropolitan-based health care provider with a focus on gastroenterology and hepatology. With 13 office locations, its physicians treat a wide range of conditions - from heartburn to constipation to fatty liver disease - and offer critical services for the prevention of colon cancer. Capital Digestive Cares integrated health care model connects its doctors to both a specialized pathology laboratory and the largest clinical research program of its kind in the region, as well as 13 hospital affiliations and 8 ambulatory surgical centers. Capital Digestive Cares physicians work together across disciplines to develop the most effective treatment plan for each patient. For more information on Capital Digestive Care, please visithttp://www.capitaldigestivecare.com/.

Story continues

Attachment

Erica BriggsCapital Digestive Care2404855200erica.briggs@capitaldigestivecare.com

Go here to read the rest:
Capital Digestive Care Taps 3 GIs for Maryland Locations - Yahoo Finance

Read the Rest...

Promising new antibiotic discovered in worm gut microbiome – New Atlas

§ November 22nd, 2019 § Filed under Nano Medicine § Tagged Comments Off on Promising new antibiotic discovered in worm gut microbiome – New Atlas

Were currently in dire need of new weapons against infectious bacteria, especially those in a tough-to-kill class known as gram-negative bacteria. Now, researchers at Northeastern University have discovered just that, hiding in the gut of a tiny, soil-dwelling, parasitic worm. Tests on mice have so far proved promising.

For decades weve had the upper hand over bacteria, clearing out many infections fairly easily with antibiotics. But extensive use has led to an arms race between us and bacteria. As they evolve resistance to our best drugs, we develop new ones and use those until the bugs become resistant to those too.

But this cycle is starting to break down, and not in our favor. Developing new drugs is time and cost-intensive process, and bacteria are evolving resistances faster than we can keep up. There are now superbugs that are resistant to all known drugs. The situation is getting so bad that a recent report warned that superbugs could kill up to 10 million people a year by 2050, casting us back into the dark ages of medicine.

We are running out of antibiotics, says Kim Lewis, director of Northeasterns Antimicrobial Discovery Center (ADC) and lead researcher on the new study. We need to be looking for novel compounds with no pre-existing resistance in the clinic or the population.

Luckily, humans arent the only organisms looking to kill bacteria other bacteria are always out for new weapons to kill off competitors for food. So rather than develop drugs from scratch, one promising avenue is to find these microscopic weapons of war and adapt them for our own use.

Matthew Modoono/Northeastern University

And now, a team from the ADC has done just that. The new antibiotic, dubbed darobactin, was discovered in the gut microbiome of nematodes. These tiny worms are parasites that live inside the digestive systems of caterpillars and other insects. Once there, they release a bacteria called Photorhabdus, which kill the caterpillar so that both the worm and bacteria can feast on it.

And in order to prevent other opportunistic microbes from stealing the meal, the Photorhabdus produce an antibiotic compound. And this was the basis for darobactin.

Importantly, the new compound can kill gram-negative bacteria, a notoriously hardy class of bugs that have a second membrane in their cell walls. The researchers found that darobactin binds to a protein called BamA, jamming the mechanism that the bug uses to build its cell wall and killing them.

The researchers tested the drug against gram-negative bacteria both in the lab and in mice, and found it to be effective. And while theres always the chance that bacteria will eventually develop resistances to any new drugs, the team noticed an interesting twist. Bugs that evolved resistance to darobactin lost the ability to infect mice. The BamA protein appears to be too important for the bacteria to change, and hopefully that should mean the drug remains unresisted for longer.

The team has previously found another antibiotic candidate in soil bacteria. In 2015, Lewiss lab discovered teixobactin, which targets gram-positive bacteria.

Of course, as promising as results in mice and lab dishes may seem, they may not carry across to humans. But the team holds out hope for these next steps.

The research was published in the journal Nature.

Source: Northeastern University

See the original post here:
Promising new antibiotic discovered in worm gut microbiome - New Atlas

Read the Rest...

Eun Ji Chung Named as IEEE New Innovator and BMES Rising Star – USC Viterbi School of Engineering

§ November 22nd, 2019 § Filed under Nano Medicine § Tagged Comments Off on Eun Ji Chung Named as IEEE New Innovator and BMES Rising Star – USC Viterbi School of Engineering

Dr. Karl Jacob Jr. and Karl Jacob III Early-Career Chair Eun Ji Chung. Photo courtesy of Viterbi Staff.

Eun Ji Chung, USC Viterbis Dr. Karl Jacob Jr. and Karl Jacob III Early-Career Chair and Assistant Professor of Biomedical Engineering, Chemical Engineering and Materials Science, has recently been honored by the Institute of Electrical and Electronics Engineers (IEEE) and the Biomedical Engineering Society (BMES) for her research in nanomedicine and bioengineering.

The IEEE has selected Chung as a NANOMED New Innovator, with the award to be presented at the IEEE International Conference on Nano/Molecular Medicine and Engineering in Gwangju, Korea on 21 24 November. The latest honor recognizes Chungs eminent research activities in the field of nanomedicine and molecular engineering as well as her continuous contribution to the IEEE-NANOMED community.

Meanwhile the BMES will honor Chung with the 2020 Rising Star Junior Faculty Award, to be presented at the BMES Cell and Molecular Bioengineering conference on January 2 6 in Puerto Rico. Chung will be recognized at the conference gala, and will be invited to present at the event. The BMES describes the Rising Star Award as a leading form of recognition of outstanding research in the field of cell and molecular bioengineering.

Chung and her research groupinvestigate molecular design, nanomedicine and tissue engineering to generate biomaterial strategies for clinical applications. A key focus of Chungs labs research involves the design and application of self-assembling, peptide nanoparticles for targeted cardiovascular and cancer treatments, as well as for the treatment of kidney disease.

A faculty member of theUSC Michelson Center for Convergent Bioscience, Chung received her B.A. in Molecular Biology with honors from Scripps College, Claremont, California, and her Ph.D. from the Interdisciplinary Biological Sciences Program and the Department of Biomedical Engineering from Northwestern University.

She was recently named 2019 Orange County Engineering Council Outstanding Young Engineer and a Journal of Materials Chemistry B Emerging Investigator for 2019.

Last year, Chung was awarded the NIH New Innovator Award to develop a new approach to a type of kidney disease, known as autosomal dominant polycystic kidney disease, the most commonly inherited kidney disorder.

Chung is a recipient of the SQI-Baxter Early Career Award, the American Heart Association Postdoctoral Fellowship, the Postdoctoral Research Grant from the Chicago Biomedical Consortium, and the K99/R00 Pathway to Independence Award from the NIH. She is a member of the Society for Biomaterials, the BMES, and the American Institute for Chemical Engineers.

See the article here:
Eun Ji Chung Named as IEEE New Innovator and BMES Rising Star - USC Viterbi School of Engineering

Read the Rest...

Nanoparticle therapy shows promise for treatment of rare cancer – The Brown Daily Herald

§ November 22nd, 2019 § Filed under Nano Medicine § Tagged Comments Off on Nanoparticle therapy shows promise for treatment of rare cancer – The Brown Daily Herald

This month, a paper published by University researchers Richard Terek and Qian Chen highlighted a potential nanotechnology therapy that targets chondrosarcoma, a rare type of bone cancer. Using nanoparticles, the team effectively delivered therapies directly into tumor cells and observed decreases in tumor volume and prolonged survival in mouse models.

Chondrosarcoma currently has no FDA approved treatments. The complex makeup of these cancer cells makes them uniquely difficult to treat. Specifically, one challenge to (drug) delivery in chondrosarcoma is the negatively charged proteoglycan-rich extracellular matrix that needs to be penetrated to reach the tumor cells, according to the study.

Terek, the chief of musculoskeletal oncology at Rhode Island Hospital, an orthopedic oncology surgeon with the Lifespan Cancer Institute and a professor of orthopedic surgery at Warren Alpert, studies chondrosarcoma and collaborated with Chen, a molecular and nano-medicine researcher, director of the NIH-funded Center of Biomedical Research Excellence in Skeletal Health and Repair at Rhode Island Hospital and a professor of orthopedic research and medical science, on this study. The pair aimed to develop a nanopiece delivery platform capable of penetrating the convoluted chondrosarcoma matrix.

We develop nanomaterial (that) we call nanopieces and we found that it can deliver nucleic acid therapeutics to tissues that normally are very difficult to be penetrated, Chen said.

In addition to getting drugs to the tumor tissue, the researchers also studied the biology of how chondrosarcoma spreads. The other thing is we dont totally understand what drives cancer cells to metastasize. That part of the work involves trying to disentangle which types of pathways have gone awry, Terek said.

The underlying principle of the therapy is that miRNA, short 21-nucleotide sequences, are overexpressed in chondrosarcoma tumor cells. These miRNA end up functioning in a way similar to oncogenes, genes which drive cancer formation, by indirectly affecting other genes in the cancer pathway.

Tereks work over the past decade has culminated in the identification of the cancer-causing, or oncogenic, miRNA involved in chondrosarcoma formation. That process involved microarray analysis of primary human tumor tissues. We used a variety of screening techniques to identify which miRNA were overexpressed in tumors, Terek said.

These detrimental effects of the oncogenic miRNA can be prevented by synthesizing a molecule of the opposite sequence of nucleotides. Once delivered into the cell with the nanoparticles it will counteract and annihilate the overexpressed miRNA Terek said.

Once the target miRNA was identified, the small, opposing sequence of RNA needed to be delivered, a process that is normally very difficult because of the charge and structure of the matrix formed by the tumor. What we do in the lab is formulate this nanomaterial specifically for penetrating into the matrix, Chen said.

The laws kind of break down when you get to these nano levels. At the nano level, these particles somehow get through the cell wall and into the cell, even though the cell wall is classically thought of as this impenetrable structure around the cell, Terek said.

The nanomaterial delivery vehicle is composed of a small molecule, weighing about 400 daltons, which assembles into a nanotube structure that contains RNA. The molecule itself is biomimetic. Its half composed of nucleic bases and half of the molecule is amino acids, so its fused together. Because of that it also has a very low level of cell toxicity, Chen said. The nanoparticle is designed to be comparable to a natural biological structure, enabling the particle to be generally accepted by cells, so it can enter and affect them.

In previous studies, Chens lab has shown successful use of nanoparticle therapy in the treatment of multiple other diseases, including rheumatoid arthritis. Recently, they also received a grant from the National Institutes of Health funding research on the treatment of Alzheimers disease using a similar nanopiece delivery system that can traverse the blood brain barrier.

In further developing this drug therapy, Terek said one possibility is to combine multiple miRNA sequences with these nanoparticles to impact more pathways and get maximal inhibition of tumor spread. This involves both counteracting overexpressed miRNA, and restoring beneficial cancer suppressor miRNAs to combine multiple therapeutics with one dose of the nanoparticles.

Another potential approach is to pair the miRNA therapy with other cancer drug therapies. Since some miRNAs prevent the effective use of typical cancer treatment drugs, this approach can be used to reverse drug resistance, allowing for the use of conventional therapies, like chemotherapy.

In order for nanoparticle therapy development to succeed, investors, pharmaceutical companies, biotech companies and other collaborators need to give time and money to projects like this, Chen said. As far as moving it into the clinic, thats always a big hurdle, Terek said. One intermediate step the team might take is to collaborate with veterinarians allowing them to incorporate their treatment method beyond mouse models.

Brown and Lifespan have helped establish a startup called NanoDe so that we can continue the process, Chen said. Moving forward, the team will continue to work on collaborating with other researchers and developers to advance this drug therapy for chondrosarcoma.

More here:
Nanoparticle therapy shows promise for treatment of rare cancer - The Brown Daily Herald

Read the Rest...

Can alternatives to rhino horn save these gentle giants? – The European Sting

§ November 20th, 2019 § Filed under Nano Medicine § Tagged Comments Off on Can alternatives to rhino horn save these gentle giants? – The European Sting

(Keith Markilie, Unsplash)

This article is brought to you thanks to the collaboration ofThe European Stingwith theWorld Economic Forum.

Author:Katharine Rooney, Senior Writer, Formative Content

Some people believe it can fight infection, treat cancer, and cure hangovers. But there is no scientific basis for the use of rhinoceros horn in medicine.

Despite this, its use an ingredient in traditional medicine has contributed to years of poaching and illegal trade; primarily to the Asian market. Between 2006-2015, 220 kilogrammes of rhino horn were seized en route to Vietnam. Within that period, nearly 9,000 rhinos across Africa have been killed by poachers.

In an effort to disrupt the market and protect the global rhino population, scientists and campaigners have introduced alternatives to rhino horn that they hope will undermine demand and devalue it as a commodity. Here are three examples.

Swedish wildlife photographer Bjorn Persson has been collecting fingernails. Human nails are made of keratin the same substance as rhino horn and Persson intends to use the materials that he has gathered to replicate the medicine thats popular in Asia.

Persson, who regularly photographs wild rhinos in Africa, says he already has thousands of dollars worth of keratin to produce the medicine.

Were asking people to donate their nails, and were going to make a medicine [to] sell to China and Vietnam as a substitute, he says.

Between 2006-2015, 220 kg of illegal rhino horn was seized en route to Vietnam.

Image: Statista

Scientists from the University of Oxford and Fudan University in Shanghai have come up with a way to create fake rhino horn using horse hair. Since rhino horns are made up of tightly packed hair, it has a similar composition when glued together.

Professor Fritz Vollrath, from the University of Oxfords Department of Zoology, says: It appears from our investigation that it is rather easy as well as cheap to make a bio-inspired hornlike material that mimics the rhinos extravagantly expensive tuft of nose hair.

The researchers hope that their discovery will not only undermine the trade in rhino horn by eventually flooding and confusing the market with credible fakes, but also find new uses as an innovative bio-material.

Two rhinos are poached in Africa every day

Image: Reuters/Jean Bizimana

A start-up in Seattle has trialled its own mock rhino horn, created with a 3D printer. Biotech firm Pembients horn alternatives are made in a lab, and are genetically identical to real ones on the macroscopic, microscopic, and molecular level, according to CEO and cofounder Matthew Markus.

By pushing fabricated horns into the supply chain at various points, he says, people wont know whether theyre buying real rhino horns or fake ones.

Rhino conservation organizations are unconvinced by such efforts, suggesting that flooding the market with inexpensive copies will only drive up demand for the genuine article.

Research shows that despite fake horns already being on the market, an average of two rhinos are still poached in Africa every day.

And yet Persson and those like him are determined to continue their efforts.

We need to create a debate in the world, he says. We need to spread awareness about what is going on, because these rhinos, they are killed for nothing. Its a meaningless extinction.

Read the original:
Can alternatives to rhino horn save these gentle giants? - The European Sting

Read the Rest...

Cryptosporidiosis And Other Intestinal Parasitic Infections And Concom | HIV – Dove Medical Press

§ November 20th, 2019 § Filed under Nano Medicine § Tagged Comments Off on Cryptosporidiosis And Other Intestinal Parasitic Infections And Concom | HIV – Dove Medical Press

Blatu Gebre,1 Tsegaye Alemayehu,2 Mekonin Girma,2 Freshwork Ayalew,2 Birkneh Tilahun Tadesse,3 Techalew Shemelis2

1Hawassa University, College of Natural and Computational Sciences, Department of Biology, Hawassa, Ethiopia; 2Hawassa University, College of Medicine and Health Sciences, School of Medical Laboratory Science, Hawassa, Ethiopia; 3Hawassa University, College of Medicine and Health Sciences, Department of Pediatrics and Child Health, Hawassa, Ethiopia

Correspondence: Tsegaye AlemayehuHawassa University College of Medicine and Health Sciences, School of Medical Laboratory Science, P.O. Box: 1560, Hawassa, EthiopiaTel +2519-13-872-24-12Email alemayehutsegaye@ymail.com

Background: Children infected with human immunodeficiency virus (HIV) are at high risk of acquiring intestinal parasitic infections. This study aimed to determine the magnitude of Cryptosporidium and other intestinal parasitic infections and concomitant threats among HIV-infected children.Methods: A hospital-based cross-sectional study was carried out at three antiretroviral therapy clinics in southern Ethiopia from February 2016 to June 2017 in 384 HIV positive children. Socio-demographic and clinical data were collected using structured questionnaires. Direct stool microscopic examination and modified ZeihlNeelsen staining technique to identify parasites. Chi-square test was conducted to determine the real predictors of the infection. Significant association was considered when p-value <0.05 at 95% CI.Results: The overall magnitude of intestinal parasitic infections among the study population was 16.9% (95% CI: 13.020.8%). The most predominant parasitic infections were Cryptosporidium spp. (9.6%) and the least was Taenia spp. (0.78%). Diarrheal status (2=7.653, df=2, p=0.022) was detected to be the only significant associated variable.Conclusion: Cryptosporidium infection was found to be the most common intestinal parasitosis among HIV-infected children. Routine screening service for Cryptosporidium and other intestinal parasites is important in the clinical management of HIV-infected children.

Keywords: intestinal parasites, Cryptosporidium, HIV/AIDS, Southern Ethiopia

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Read the original here:
Cryptosporidiosis And Other Intestinal Parasitic Infections And Concom | HIV - Dove Medical Press

Read the Rest...

Alteration of Amino Acid Profiling Influenced by the Active Ingredient | DDDT – Dove Medical Press

§ November 20th, 2019 § Filed under Nano Medicine § Tagged Comments Off on Alteration of Amino Acid Profiling Influenced by the Active Ingredient | DDDT – Dove Medical Press

Zhili Guo,1 Yan Zhu,2 Wenjuan Xu,3 Kaitao Luo,1 Hongbin Xiao,4 Zhong Wang3

1Chinese Medicine Department, Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing University, Jiaxing, Zhejiang, 314000, Peoples Republic of China; 2Chinese Medicine Department, Beijing Electric Power Hospital, Capital Medical University, Beijing 10073, Peoples Republic of China; 3Chinese Medicine Pharmacology, Institute of Basic Research in Clinical Medicine. China Academy of Chinese Medical Sciences, Beijing 100700, Peoples Republic of China; 4Beijing University of Chinese Medicine, Chinese Medicine Institute, Beijing 100029, Peoples Republic of China

Correspondence: Kaitao Luo; Zhong Wang Tel +86057382079269; +861064014411-3308Email lkt740813@163.com; zhonw@sina.com

Introduction: The aim of this work was to optimize the formulation composition of DanHong injection and to study the disturbance of microscopic components of cerebral ischemia in amino acid metabolites and metabolic pathways. The subtle relationship among these three substances and the influence of metabolic pathways were also studied.Methods: In this study, the central composite design (CCD) matrix and response surface methodology (RSM) were used to design the experiments and to evaluate the interactive effects of three substances. Targeted metabolomics was used to detect the amino acid variation in CCD sets.Results: Response surfaces were generated, and the formulation was optimized by superimposing the contour plots. It was found that the optimum values of the responses could be obtained at an SAB concentration (x1) of 89 mg/kg, a TSN concentration (x2) of 1416 mg/kg, and an HSYA yellow A concentration (x3) of 6 mg/kg. Statistical analysis showed that the three independent variables had significant effects (p < 0.05) on the responses. A total of 22 experimental runs were performed, and the kinetic data were analyzed using a second-order polynomial. Model algorithm calculation indicated that glutamic acid, serine, leucine, glycine, and valine had a very close correlation with the active ingredients. Methionine, aspartic acid, asparagine, glutamic acid, and valine were important for distinguishing different groups, and they were identified as potential biomarkers. Cluster analysis and pathway analysis indicated that the valine, leucine, and isoleucine degradation (VLI degradation) pathway was the major metabolic pathway. Arginine and proline metabolites were most frequently detected, and they were closely associated with other networks according to the network analysis results. VLI degradation pathway and arginine and proline metabolism pathway had a significant influence on cerebral ischemia.Discussion: The integration of CCD and metabolomics may be an effective strategy for optimizing the formulation composition and identifying the mechanism of action of traditional chinese medicine.

Keywords: amino acid metabolomics, central composite design, metabolic pathways, cerebral ischemia, DanHong injection, HPLC-FLD test, traditional Chinese medicine

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Read more:
Alteration of Amino Acid Profiling Influenced by the Active Ingredient | DDDT - Dove Medical Press

Read the Rest...

« Older Entries Newer Entries »



Page 4«..3456..1020..»